Assignee
JACKSON LAB
US73 patents
Top patents by PatentIndex Score
US6992234B2Jan 31, 2006
FcRn-based therapeutics for the treatment of auto-immune disorders
JACKSON LAB136 citations96
US7191734B2Mar 20, 2007
Apparatus for transporting laboratory animals
JACKSON LAB59 citations95
US4922180AMay 1, 1990
Controlled microwave sample irradiation system
JACKSON LAB144 citations95
US4911555AMar 27, 1990
Magnetic stirrer for multiple samples
JACKSON LAB63 citations93
US4518595AMay 21, 1985
Method for treating diabetes using DHEA compounds
JACKSON LAB54 citations91
US7358416B2Apr 15, 2008
Transgenic mouse expressing human FcRn protein
JACKSON LAB21 citations90
US4947487AAug 14, 1990
Laser beam protective gloves
JACKSON LAB27 citations90
US5686598ANov 11, 1997
Genes associated with retinal dystrophies
JACKSON LAB19 citations89
US4666898AMay 19, 1987
Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones
JACKSON LAB27 citations89
US7772569B2Aug 10, 2010
3D biplane microscopy
JACKSON LAB38 citations88
US4959313ASep 25, 1990
Cellular enhancer for expressing genes in undifferentiated stem cells
JACKSON LAB52 citations88
US7880149B2Feb 1, 2011
3D biplane microscopy
JACKSON LAB7 citations79
US4404590ASep 13, 1983
Video blink comparator
JACKSON LAB22 citations76
US4846109AJul 11, 1989
Animal shipping container
JACKSON LAB18 citations72
US11890322B2Feb 6, 2024
Methods for promoting wound healing and hair growth comprising GDNF administration
JACKSON LAB1 citations69
US11778994B2Oct 10, 2023
NSG mice lacking MHC class I and class II
JACKSON LAB3 citations69
US11389439B2Jul 19, 2022
Treatment and prevention of ocular neurodegenerative disorder
JACKSON LAB2 citations69
US11248236B2Feb 15, 2022
Non-HLA matched humanized NSG mouse model with patient-derived xenograft
JACKSON LAB2 citations69
US10376562B2Aug 13, 2019
Methods for promoting wound healing and hair growth comprising GDNF administration
JACKSON LAB2 citations69
US8685637B2Apr 1, 2014
Kit for sperm cryoprotection
JACKSON LAB4 citations69
US11959926B2Apr 16, 2024
Method of determining toxicity of an immunomodulatory drug for use in humans preliminary class
JACKSON LAB2 citations68
US11959925B2Apr 16, 2024
Method of determining toxicity of an immunomodulatory drug for use in humans
JACKSON LAB2 citations68
US11330804B2May 17, 2022
Long-term and continuous animal behavioral monitoring
JACKSON LAB1 citations68
US5690932ANov 25, 1997
Clinical disorders associated with carboxypeptidase E mutation
JACKSON LAB6 citations68
US10701911B2Jul 7, 2020
Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
JACKSON LAB2 citations66
US9938565B2Apr 10, 2018
Compositions for RNA-chromatin interaction analysis and uses thereof
JACKSON LAB2 citations65
US5994620ANov 30, 1999
Induced chromosomal deletion
JACKSON LAB8 citations65
US9237740B2Jan 19, 2016
Compositions and methods relating to non-human animals modified to promote production of selected gametes
JACKSON LAB2 citations60
US12577584B2Mar 17, 2026
Non-HLA matched humanized NSG mouse model with patient-derived xenograft
JACKSON LAB0 citations59
US12378574B2Aug 5, 2025
Transgenic mouse models supporting innate immune function
JACKSON LAB0 citations59
US12336986B2Jun 24, 2025
Treatment and prevention of ocular neurodegenerative disorder
JACKSON LAB0 citations59
US11369695B2Jun 28, 2022
Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
JACKSON LAB0 citations59
US12357674B2Jul 15, 2025
Methods for promoting wound healing and hair growth comprising GDNF administration
JACKSON LAB0 citations58
US12347112B2Jul 1, 2025
Long-term and continuous animal behavioral monitoring
JACKSON LAB0 citations58
US11798167B2Oct 24, 2023
Long-term and continuous animal behavioral monitoring
JACKSON LAB0 citations58
US12510548B2Dec 30, 2025
Method of determining toxicity of an immunomodulatory drug for use in humans
JACKSON LAB0 citations57
US12196744B2Jan 14, 2025
Humanized mouse models for assessing immune cell therapy
JACKSON LAB1 citations57
US7822556B2Oct 26, 2010
Expression data analysis systems and methods
JACKSON LAB3 citations57
US5593837AJan 14, 1997
Clinical disorders associated with carboxypeptidase E mutation
JACKSON LAB4 citations57
US11785923B2Oct 17, 2023
Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
JACKSON LAB0 citations56
US12428638B2Sep 30, 2025
Three-component CRISPR/Cas complex system and uses thereof
JACKSON LAB0 citations55
US11434484B2Sep 6, 2022
Three-component CRISPR/Cas complex system and uses thereof
JACKSON LAB1 citations55
US11466307B2Oct 11, 2022
Compositions for RNA-chromatin interaction analysis and uses thereof
JACKSON LAB0 citations54
US11136377B2Oct 5, 2021
Antibodies and Fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
JACKSON LAB0 citations54
US11074991B2Jul 27, 2021
Methods for multiplex chromatin interaction analysis by droplet sequencing with single molecule precision
JACKSON LAB1 citations54
US11780895B2Oct 10, 2023
Targeted DNA demethylation and methylation
JACKSON LAB1 citations53
US11957115B2Apr 16, 2024
Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof
JACKSON LAB0 citations52
US11674187B2Jun 13, 2023
Breast cancer splice variants
JACKSON LAB0 citations51
US5811244ASep 22, 1998
In vitro method for identifying a clinical disorder associated with Nhe1 mutation
JACKSON LAB2 citations50
US7196171B2Mar 27, 2007
Alströem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alströem syndrome
JACKSON LAB4 citations49
Showing the top 50 of 73 patents by PatentIndex Score.